som fik MabThera i kliniske studier eller i forbindelse med post- marketing overvågning.
Summary of Adverse Drug Reactions Reported in Clinical Trials or During Postmarketing Surveillance Occurring in Patients with Rheumatoid Arthritis receiving MabThera